Exact Mass: 505.14514840000004
Exact Mass Matches: 505.14514840000004
Found 151 metabolites which its exact mass value is equals to given mass value 505.14514840000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
alangiside
C25H31NO10 (505.19478660000004)
An organic heterotetracyclic compound that is an alkaloidal glycoside isolated from Alangium salviifolium.
Cyanidin 3-O-(6'-malonyl-arabinoside)
Cyanidin 3-O-(6-malonyl-arabinoside) is a polyphenol compound found in foods of plant origin (PMID: 20428313)
N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
C21H22F3NO8S (505.10181680000005)
Peonidin 3-(6'-acetyl-galactoside)
Peonidin 3-(6-acetyl-galactoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-galactoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-galactoside) can be found in highbush blueberry and lowbush blueberry, which makes peonidin 3-(6-acetyl-galactoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6'-acetyl-glucoside)
Peonidin 3-(6-acetyl-glucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-glucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-glucoside) can be found in common grape, grape wine, highbush blueberry, and lowbush blueberry, which makes peonidin 3-(6-acetyl-glucoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6-acetylglucoside)
10-(Methylthio)decyl glucosinolate
C18H35NO9S3 (505.14738600000004)
3-O-demethyl-2-O-methylisoalangiside
C25H31NO10 (505.19478660000004)
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-tyrosyl]glucopyranoside
Glu Asp Gln Asp
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
C25H28ClNO8 (505.15033580000005)
Ala Asp Asp Trp
C22H27N5O9 (505.1808692000001)
Ala Asp Trp Asp
C22H27N5O9 (505.1808692000001)
Ala Trp Asp Asp
C22H27N5O9 (505.1808692000001)
Asp Ala Asp Trp
C22H27N5O9 (505.1808692000001)
Asp Ala Trp Asp
C22H27N5O9 (505.1808692000001)
Asp Asp Ala Trp
C22H27N5O9 (505.1808692000001)
Asp Asp Glu Gln
Asp Asp Gln Glu
Asp Asp Trp Ala
C22H27N5O9 (505.1808692000001)
Asp Glu Asp Gln
Asp Glu Glu Asn
Asp Glu Gly Trp
C22H27N5O9 (505.1808692000001)
Asp Glu Asn Glu
Asp Glu Gln Asp
Asp Glu Trp Gly
C22H27N5O9 (505.1808692000001)
Asp Gly Glu Trp
C22H27N5O9 (505.1808692000001)
Asp Gly Trp Glu
C22H27N5O9 (505.1808692000001)
Asp Asn Glu Glu
Asp Gln Asp Glu
Asp Gln Glu Asp
Asp Trp Ala Asp
C22H27N5O9 (505.1808692000001)
Asp Trp Asp Ala
C22H27N5O9 (505.1808692000001)
Asp Trp Glu Gly
C22H27N5O9 (505.1808692000001)
Asp Trp Gly Glu
C22H27N5O9 (505.1808692000001)
Glu Asp Asp Gln
Glu Asp Glu Asn
Glu Asp Gly Trp
C22H27N5O9 (505.1808692000001)
Glu Asp Asn Glu
Glu Asp Trp Gly
C22H27N5O9 (505.1808692000001)
Glu Glu Asp Asn
Glu Glu Asn Asp
Glu Gly Asp Trp
C22H27N5O9 (505.1808692000001)
Glu Gly Trp Asp
C22H27N5O9 (505.1808692000001)
Glu Asn Asp Glu
Glu Asn Glu Asp
Glu Gln Asp Asp
Glu Trp Asp Gly
C22H27N5O9 (505.1808692000001)
Glu Trp Gly Asp
C22H27N5O9 (505.1808692000001)
Gly Asp Glu Trp
C22H27N5O9 (505.1808692000001)
Gly Asp Trp Glu
C22H27N5O9 (505.1808692000001)
Gly Glu Asp Trp
C22H27N5O9 (505.1808692000001)
Gly Glu Trp Asp
C22H27N5O9 (505.1808692000001)
Gly Trp Asp Glu
C22H27N5O9 (505.1808692000001)
Gly Trp Glu Asp
C22H27N5O9 (505.1808692000001)
Asn Asp Glu Glu
Asn Glu Asp Glu
Asn Glu Glu Asp
Gln Asp Asp Glu
Gln Asp Glu Asp
Gln Glu Asp Asp
Trp Ala Asp Asp
C22H27N5O9 (505.1808692000001)
Trp Asp Ala Asp
C22H27N5O9 (505.1808692000001)
Trp Asp Asp Ala
C22H27N5O9 (505.1808692000001)
Trp Asp Glu Gly
C22H27N5O9 (505.1808692000001)
Trp Asp Gly Glu
C22H27N5O9 (505.1808692000001)
Trp Glu Asp Gly
C22H27N5O9 (505.1808692000001)
Trp Glu Gly Asp
C22H27N5O9 (505.1808692000001)
Trp Gly Asp Glu
C22H27N5O9 (505.1808692000001)
Trp Gly Glu Asp
C22H27N5O9 (505.1808692000001)
4-[[5-(acetylamino)-1-methyl-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide
C27H27N3O5S (505.1671332000001)
Cyanidin 3-O-(6-malonyl-arabinoside)
2,2-[[3-acetamido-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate
4-Methoxyphenyl 3-O-Benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranoside
C28H27NO8 (505.17365820000003)
9H-Carbazole, 9-[1,1-biphenyl]-4-yl-3-(4-chlorophenyl)-6-phenyl-
C36H24ClN (505.15971740000003)
(S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide
C23H25F6N3OS (505.16224320000003)
4-(FMOC-2-AMINOETHYL)-6-DIBENZOFURANPROPIONIC ACID
C32H27NO5 (505.18891320000006)
Dasatinib hydrate
C22H28ClN7O3S (505.1662768000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
4-Methylumbelliferyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside
C24H27NO11 (505.15840320000007)
Omipalisib
C25H17F2N5O3S (505.1020116000001)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3]. Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3].
4-Methylumbelliferyl 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-Galactopyranoside
C24H27NO11 (505.15840320000007)
peonidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-acetyl-beta-D-glucosyl residue.
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
C21H22F3NO8S (505.10181680000005)
5-chloro-2-propyl-3-[4-[4-[2-(2H-tetrazol-5-ylmethyl)phenyl]phenyl]phenyl]imidazo[4,5-b]pyridine
(11S,12aR,13aR)-12-ethenyl-11-(beta-D-glucopyranosyloxy)-2-hydroxy-3-methoxy-5,6,12,12a,13,13a-hexahydro-11H-pyrano[4,3:4,5]pyrido[2,1-a]isoquinolin-8-one
C25H31NO10 (505.19478660000004)
2,4-difluoro-N-[2-methoxy-4-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
C25H17F2N5O3S (505.1020116000001)
2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C23H28BrN3O5 (505.12122180000006)
4-[(5-acetamido-1-methylindol-3-yl)methyl]-3-methoxy-N-(2-methylphenyl)sulonylbenzamide
C27H27N3O5S (505.1671332000001)
[(1S)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29F2N3O4S (505.1846738000001)
[(1R)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C25H29F2N3O4S (505.1846738000001)
(E)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enamide
C25H31NO10 (505.19478660000004)
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
C25H28ClNO8 (505.15033580000005)
SRT 1720 (monohydrochloride)
C25H24ClN7OS (505.14514840000004)
SRT 1720 monohydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3[1].
methyl 2-{14-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl}acetate
C25H31NO10 (505.19478660000004)
10-(3-hydroxyphenyl)-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaene-5,12,14,24-tetrol
C32H27NO5 (505.18891320000006)
methyl 2-[(4r,6r,7s)-14-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl]acetate
C25H31NO10 (505.19478660000004)
(3r,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2r,3r,4s,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(10s,18s)-10-(3-hydroxyphenyl)-19-azahexacyclo[20.2.2.1⁸,¹⁹.0²,⁷.0¹⁰,¹⁸.0¹¹,¹⁶]heptacosa-1(25),2,4,6,8(27),11,13,15,22(26),23-decaene-5,12,14,24-tetrol
C32H27NO5 (505.18891320000006)
(3s,4r,4as,5ar)-4-ethenyl-6-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enimidic acid
C25H31NO10 (505.19478660000004)
3,5,24,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one
(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate
(4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(2e)-n-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enimidic acid
C25H31NO10 (505.19478660000004)
(3s,4r,4as,5as)-4-ethenyl-8-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
1-[(2r,3r,4s,5r)-5-({[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid
methyl 5-ethyl-4-(2-oxo-2-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy}ethyl)pyridine-3-carboxylate
C25H31NO10 (505.19478660000004)
methyl 5-ethyl-4-[2-oxo-2-({3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl}methoxy)ethyl]pyridine-3-carboxylate
C25H31NO10 (505.19478660000004)
3-{[(2s,3r,4r,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(3s,4s,4as,5ar)-4-ethenyl-6-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
(3s,4s,4as,5as)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
3-{[(3r,4s,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
4-ethenyl-7-hydroxy-8-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
4-ethenyl-8-hydroxy-7-methoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)
3-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1λ⁴-chromen-1-ylium
(13r,21r,24s)-3,5,24,28-tetrahydroxy-21-methoxy-7-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,20(25),27-nonaen-26-one
2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-amino-3-(4-hydroxyphenyl)propanoate
4-ethenyl-7-hydroxy-8-methoxy-3-{[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
C25H31NO10 (505.19478660000004)